Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.

Similar Items

• Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
  od: Jacobson, M A, i dr.
  Izdano: (1989)
• Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053).
  od: Aweeka, F T, i dr.
  Izdano: (1992)
• Failure of adjunctive cytomegalovirus intravenous immune globulin to improve efficacy of ganciclovir in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: a phase 1 study.
  od: Jacobson, M A, i dr.
  Izdano: (1990)
• Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitis.
  od: Jacobson, M A, i dr.
  Izdano: (1994)
• Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection.
  od: Sjövall, J, i dr.
  Izdano: (1989)